Back
Cardiff Oncology 10K Form
Buy
58
CRDF
Cardiff Oncology
Last Price:
$4.14
Seasonality Move:
13.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRDF News And Ratings
See the #1 stock for the next 7 days that we like better than CRDF
CRDF Financial Statistics
Sales & Book Value
Annual Sales: | $683K |
---|---|
Cash Flow: | $-12.8M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.07 |
Price / Book: | 3.82 |
Profitability
EPS (TTM): | -0.92000 |
---|---|
Net Income (TTM): | $-48.9M |
Gross Margin: | $240K |
Return on Equity: | -77.18% |
Return on Assets: | -63.45% |
Cardiff Oncology Earnings Forecast
Key Cardiff Oncology Financial Ratios
-
The Gross Profit Margin over the past 10 years for CRDF is 98.11%.
-
The Selling, General & Administrative Expenses for CRDF have been equal to 1,827.53% of Gross Profit Margin.
-
The Research & Development expenses have been 5,395.61% of Revenue.
-
The Net Earning history of CRDF is -6,651.68% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 7 years.
Cardiff Oncology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CRDF |
CUSIP: | 14147L |
Website: | cardiffoncology.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.22 |
Quick Ratio: | 6.04 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CRDF Technical Analysis vs Fundamental Analysis
Buy
58
Cardiff Oncology (CRDF)
is a Buy
Is Cardiff Oncology a Buy or a Sell?
-
Cardiff Oncology stock is rated a BuyThe current Cardiff Oncology [CRDF] share price is $4.07. The Score for CRDF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.